FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
The US has taken its first steps to establish legal limits over AI use by publishing a voluntary code to ensure responsible corporate use of AI.
With temporary waivers of restriction relating to telehealth likely to end soon, here’s a roundup of the current state of state telehealth licensing law.
The final Outpatient Prospective Payment System Final Rule for 2023 provides for a rate increase of nearly four percent.
Despite Congress’ clear policy on private insurer payment of COVID-19 tests, many labs have been struggling to get reimbursed.
Though Congress didn’t pass VALID as part of the medical devices user fees bill, there’s still a good chance it will pass before year’s end.
Sentencing has been postponed for one month to explore possible government mishandling of key witness testimony.
What you need to know about the 308-page proposed rule and its potential impact on your lab, along with a basic strategy to implement it.
The problems began in January 2020 when hackers got access to an employee’s email account, compromising clients’ personal data.
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
After the price transparency rules took effect in January 2021, CMS finally issued the first penalties for violations.